Global Hormonal Contraceptives Market - Snapshot

The global hormonal contraceptives market is expanding at a significant rate, owing to increase in awareness, worldwide, about population growth. The global hormonal contraceptives market was valued at US$ 19,500 Mn in 2017 and is estimated to reach more than US$ 30,930.5 Mn by 2026, expanding at a CAGR of over 5% from 2018 to 2026. The global hormonal contraceptives market is witnessing expansion at a relatively significant growth rate owing to increase in technological advancements, high prevalence of obesity, and rise in PCOS across the globe.

Contraceptives can be defined as a drug or device that can prevent pregnancy. Contraceptives can be of various types such as hormonal and non-hormonal. Hormonal contraceptives are the type of contraceptives that act on the endocrine system for birth control. Hormonal contraception regulates the hormonal changes in a female’s menstrual cycle by using different hormones that are analogue of progesterone and estrogen. Demand for hormonal contraceptives is rising owing to the increase in prevalence of women’s health related problems such as PCOS, delayed child bearing, and rise in awareness about population control.

The global hormonal contraceptives market is projected to expand at a steady CAGR during the forecast period. Increase in infertility rate across the globe is an important factor that is expected to drive the market during the forecast period. Other factors such as rise in lifestyle-related diseases, high prevalence of PCOS, obesity, and delayed child-bearing due to financial instability are expected to boost the global market from 2018 to 2026. Furthermore, rise in awareness about population control in developed countries and various government programs for family planning in several developing countries are other important factors that are likely to propel the global hormonal contraceptives market during the forecast period. However, alternative contraceptive methods, side effects of the hormonal drugs, and lack of social acceptance in several developing countries are some factors that are likely to restrain the global hormonal contraceptives market during the forecast period.

hormonal-contraceptives-market.jpg

The global hormonal contraceptives market has been segmented based on method, hormones, distribution channel, and region. In terms of method, the market has been classified into oral contraceptives, transdermal patches, injectable contraceptives, intrauterine contraceptives, and vaginal rings. The oral contraceptives segment is expected to hold a significant share of the global market since they are easier to use, effective, and results are readily available.

Based on hormones, the global hormonal contraceptives market has been divided into progestin only and combined hormones. The combined hormones segment held a prominent share of the market, in terms of revenue, in 2017. Increase in prevalence of PCOS and fewer side effects and effective results, as compared to progestin contraceptives, are some factors that are anticipated to propel the segment during the forecast period.

In terms of distribution channel, the global market has been segregated into drug stores, gynecology/fertility clinics, E-commerce, and others. The drug stores segment accounted for a major share of the market in 2017, in terms of revenue. Rise in trend of OTC sales is a key factor that is likely to drive the market during the forecast period

North America held a significant share of the global hormonal contraceptives market, in terms of revenue, in 2017, followed by Europe. Rise in obesity, high awareness of people about population control, prevalence of infertility, and PCOS in the region are key factors boosting the market in North America. Developed countries such the U.K. and Germany exhibit higher awareness about hormonal contraceptives and their applications. This is expected to boost the market in the region. The market in Asia Pacific is expanding at a rapid pace. Countries such as China, India, and Japan offer significant opportunities to the market due to increase in population, rising prevalence of lifestyle-related diseases, rise in infertility, PCOS, and government programs for family planning.

Key players in the global market are adopting strategies such as mergers and acquisitions, technological development, and geographic expansion in order to capture significant position in the global market. Major players operating in the global hormonal contraceptives market include ALLERGAN, Afaxys, Inc., Bayer AG, Agile Therapeutics, Inc., Merck & Co., Inc., Pfizer Inc., HLL Lifecare Limited, and Piramal Enterprises.

Global Hormonal Contraceptives Market: Scope and Methodology

This report analyzes the current and future prospects of the global hormonal contraceptives market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of the research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2018 to 2026, considering the macro and micro environmental factors. Growth rates for each segment in the global hormonal contraceptives market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining the market and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global hormonal contraceptives market.

Market revenue in terms of US$ Mn for the period between 2016 and 2026 along with the compound annual growth rate (CAGR %) from 2018 to 2026 are provided for all the segments, considering 2017 as the base year. Market size estimations involved in-depth study of features of different types of product types. Additionally, market related factors such as rise in prevalence PCOS, product launch, and historical year-on-year growth have been taken into consideration while estimating the market size.

Hormonal Contraceptives Market: Segmentation

Contraceptives can be defined as a drug or device that can prevent pregnancy. Contraceptives can be of various types such as hormonal and non-hormonal. Hormonal contraceptives are a type of contraceptives that act on the endocrine system for birth control. Demand for hormonal contraceptives market is rising owing to the increase in prevalence of women’s health-related problems such as PCOS and delayed child bearing.

Based on method, the global hormonal contraceptives market has been classified into oral contraceptives, transdermal patches, injectable contraceptives, intrauterine contraceptives, and vaginal rings. The oral contraceptives segment is expected to hold a significant share of the global market during the forecast period.

In terms of hormones, the global hormonal contraceptives market has been segregated into progestin only and combined hormones. The combined hormones segment is anticipated to dominate the market from 2018 to 2026.

Based on distribution channel, the global hormonal contraceptives market has been segmented into drug stores, gynecology/ fertility clinics, E-commerce, and others. The drug stores segment held a prominent share of the global market, in terms of revenue, in 2017.

Global Hormonal Contraceptives Market: Geographical and Competitive Dynamics

In terms of geography, the global hormonal contraceptives market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries.

The report also profiles major players in the global hormonal contraceptives market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include ALLERGAN, Afaxys, Inc., Bayer AG, Agile Therapeutics, Inc., Merck & Co., Inc., Pfizer Inc., HLL Lifecare Limited, and Piramal Enterprises.

The global hormonal contraceptives market has been segmented as follows:

Global Hormonal Contraceptives Market, by Method

  • Oral Contraceptives
  • Transdermal Patches
  • Injectable Contraceptives
  • Intrauterine Contraceptives
  • Vaginal Rings

Global Hormonal Contraceptives Market, by Hormones

  • Progestin Only
  • Combined Hormones

Global Hormonal Contraceptives Market, by Distribution Channel

  • Drug Stores
  • Gynecology/ Fertility Clinics
  • E-commerce
  • Others

Global Hormonal Contraceptives Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa
.